Latest Innovation News

NeuroScientific Biopharmaceuticals has completed its acquisition of StemSmart stem cell technology, setting the stage for a focused clinical push in treating fistulising Crohn’s disease. The company also refreshed its board and raised $7.5 million to support this next phase.

PYC Therapeutics has announced promising pre-clinical results for its RNA-based drug candidate PYC-002, targeting the genetic root of Phelan-McDermid Syndrome, with clinical trials expected to begin in 2026.

ALS Limited reported a robust FY25 with 16% revenue growth to AUD 3 billion, underpinned by strong organic expansion and key acquisitions. Despite slight NPAT decline, the company advances its sustainability agenda and invests in global lab upgrades.

Sprintex secures a key deposit from Mest Water to develop new compressors for mobile manure processing systems, leveraging a Dutch government subsidy aimed at thousands of small farms.

Range International’s Indonesian subsidiary has successfully overturned 2018 tax assessments, eliminating a significant financial burden and clearing the way for focused growth.

White Energy has identified five distinct target zones with anomalous copper, zinc, nickel, gold, and rare earth elements in soil samples over geophysical structures at its Tindal project in the Northern Territory, signaling promising early-stage exploration results.

I Synergy Group Limited has successfully raised approximately $1 million through a fully underwritten entitlement offer, with robust shareholder participation and full underwriting support.

DXN Limited has secured a $1.6 million contract with Ventia to deploy its innovative StructCore prefabricated indoor data centre solution for a major Australian telecommunications provider, marking a strategic expansion into a new market segment.

HyTerra Limited expands its Nemaha Project drilling program by adding a third well, McCoy 1, marking a shift to data-driven site selection. Early gas logs from Blythe 13-20 suggest promising hydrogen and helium presence, pending lab confirmation.

SunRice reported a slight decline in FY25 revenue to $1.85 billion but achieved improved profitability, driven by strategic acquisitions and operational efficiencies. The company is investing in sustainability and capacity upgrades as it pursues its 2030 Growth Strategy.

Adherium Limited has announced a partially underwritten entitlement offer aiming to raise approximately A$4.5 million through the issuance of new shares and options at a significant discount. The capital raise is designed to accelerate patient onboarding and product development for its respiratory monitoring technology.

Adherium Limited has successfully closed the institutional portion of its entitlement offer, increasing the raise to $4.492 million due to robust demand. The company now invites retail shareholders to participate as it advances its digital respiratory health solutions.